文献速递中医内科中药与中成药合理使用

五灵胶囊通过调控尿酸转运蛋白缓解高尿酸血症并保护UA损伤的HK-2细胞

Wuling capsule alleviates hyperuricaemia and protects UA- injured HK-2 cells by regulating uric acid transporter proteins.
PubMed 文献 · Front Pharmacol · 2025-04-29

五灵胶囊是一种中成药,本研究在大鼠高尿酸血症模型中评估其降尿酸与肾脏保护作用,并在UA损伤的HK-2细胞中探讨机制与关键活性成分。结果显示五灵胶囊可降低血清UA和XOD,改善肝肾功能指标,调节URAT1、GLUT9、ABCG2和OAT1表达,其成分可提高细胞活力并抑制凋亡。

要点

  • 五灵胶囊可降低HUA大鼠血清尿酸和XOD水平。
  • 五灵胶囊改善肝肾功能指标并减轻肾脏炎症浸润。
  • 其活性成分调节URAT1、GLUT9、ABCG2等转运蛋白。

核心结论

  • 五灵胶囊通过保护肝肾功能和调控尿酸相关转运蛋白发挥治疗高尿酸血症的作用。

研究设计与样本

  • 研究采用大鼠高尿酸血症模型进行体内药效评价,并结合UA损伤的HK-2细胞进行体外机制研究。
  • 通过UPLC-QTOF-MS/MS分析五灵胶囊及其含药血清的主要成分。

主要发现

  • 在HUA大鼠中,五灵胶囊显著降低血清UA水平和血清及肝脏XOD含量。
  • 五灵胶囊改善肝功能标志物(ALT、AST)和肾损伤指标(Cr、BUN),减轻肾小管扩张和炎症浸润。
  • 五灵胶囊调节UA相关转运蛋白URAT1、GLUT9、ABCG2和OAT1的mRNA和蛋白表达。
  • 体外实验中,五灵胶囊主要成分(柴胡皂苷A、丹参酮IIA、五味子醇B和灵芝酸A)提高UA损伤HK-2细胞活力并抑制凋亡。
  • 其四种血清成分选择性调节URAT1、GLUT9和ABCG2的mRNA和蛋白表达。

临床怎么用

  • 五灵胶囊可能作为高尿酸血症的潜在治疗选择,尤其适用于需兼顾肝肾功能保护的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Wuling capsule is a Chinese patent medicine mainly used for the treatment of chronic liver disease in clinical practice. Our previous work has revealed that Wuling capsule could inhibit liver fibrosis by regulating macrophage polarization, and firstly demonstrated its anti-gout effects on monosodium urate (MSU)- induced acute gouty arthritis (AGA) in rats. High uric acid (UA) levels are known to be the primary cause of gout. Therefore, this study investigated the UA lowering, kidney protection effects and underlying mechanisms of Wuling capsule in vivo and in vitro, and also determined its key bioactive constituents. METHODS: The efficacy of Wuling capsule for HUA symptoms in rats was evaluated. Histopathological analysis of liver and kidney tissues were detected by HE staining. The biochemical indices were measured using specific kits. The main constituents of Wuling capsule and its medicated serum were analyzed by UPLC-QTOF-MS/MS. Protective effects of saikosaponin A, tanshinone IIA, schisandrol B, and ganoderic acid A on UA-injured HK-2 cells were assessed via Hoechst 33342/PI staining and flow cytometry. Molecular docking and dynamics simulation predicted the binding energy and stability of these constituents to UA related transporters. The mRNA and protein expression levels of UA related transporters were examined using RT-qPCR and Western blotting. RESULTS: In HUA rats, Wuling capsule significantly reduced the serum UA level and xanthine oxidase (XOD) content in both serum and liver. Furthermore, it improved liver function markers (ALT, AST) and renal injury indicators (Cr, BUN), ameliorated renal tubule dilation and inflammatory infiltration in the kidney, and regulated the mRNA and protein expression of UA related transporters (URAT1, GLUT9, ABCG2 and OAT1). In vitro, the main constituents of Wuling capsule (saikosaponin A, tanshinone IIA, schisandrol B and ganoderic acid A) improved cell viability and inhibited cell apoptosis in UA-injured HK-2 cells. Subsequently, its four serum constituents also significantly regulated the mRNA and protein expression of URAT1, GLUT9, and ABCG2 selectively. DISCUSSION: This work demonstrated the therapeutic effect of Wuling capsule on HUA by protecting liver and kidney function and regulating UA related transporters. These findings provide novel support for the further clinical application of Wuling capsule.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Li N, Liu H, Song Z, et al. Wuling capsule alleviates hyperuricaemia and protects UA- injured HK-2 cells by regulating uric acid transporter proteins. Front Pharmacol. 2025. PMID: 40365321. doi:10.3389/fphar.2025.1563676

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。